HCM II Acquisition [HOND] vs Cartesian Growth [RENEW] Detailed Stock Comparison
HCM II Acquisition
NASDAQ
Loading...
Cartesian Growth
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 11 vital metrics comparison: HCM II Acquisition wins in 2 metrics, Cartesian Growth wins in 1 metrics, with 2 ties. HCM II Acquisition appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
| Metric | HCM II Acquisition | Cartesian Growth | Better |
|---|---|---|---|
| Price-to-Book Ratio | 2.18 | N/A | N/A |
| Debt-to-Equity Ratio | 0.00 | 0.10 | HCM II Acquisition |
| EV/EBITDA | N/A | -944.18 | N/A |
| Profit Margin (TTM) | 0.00% | 0.00% | Tie |
| Operating Margin (TTM) | 0.00% | 0.00% | Tie |
| Return on Equity | N/A | 12.76% | N/A |
| Return on Assets (TTM) | N/A | -0.50% | N/A |
| Free Cash Flow (TTM) | N/A | $-814,232 | N/A |
| 1-Year Return | 72.29% | 5.80% | HCM II Acquisition |
| Enterprise Value | $485.18M | $1.85B | Cartesian Growth |
| Beta (Stock Volatility) | N/A | -0.01 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
HCM II Acquisition vs Cartesian Growth Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HCM II Acquisition | 4.14% | 8.54% | 49.09% | 54.59% | 63.43% | 71.09% |
| Cartesian Growth | -1.85% | -2.60% | -1.62% | 8.85% | 23.41% | 20.34% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HCM II Acquisition | 72.29% | 72.29% | 72.29% | 72.29% | 72.29% | 72.29% |
| Cartesian Growth | 5.80% | 1,583.27% | 1,912.61% | 1,912.61% | 1,912.61% | 1,912.61% |
News Based Sentiment: HCM II Acquisition vs Cartesian Growth
HCM II Acquisition
News based Sentiment: NEUTRAL
The month's primary event was the completion of a business combination and subsequent public listing of Daseke, Inc. This is a significant corporate event, but its impact on investment prospects is yet to be determined, making the overall sentiment neutral. The redemption of shares provides a clear outcome for existing investors.
Cartesian Growth
News sentiment data is not available for Cartesian Growth at this time.
Performance & Financial Health Analysis: HCM II Acquisition vs Cartesian Growth
| Metric | HOND | RENEW |
|---|---|---|
| Market Information | ||
| Market Cap | $493.35M | $1.84B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,079,671 | 1,113 |
| 90 Day Avg. Volume | 1,477,824 | 371 |
| Last Close | $17.87 | $138.87 |
| 52 Week Range | $9.90 - $18.80 | $110.08 - $147.87 |
| % from 52W High | -4.95% | -6.09% |
| All-Time High | $18.80 (Oct 06, 2025) | $147.87 (Jul 23, 2025) |
| % from All-Time High | -4.95% | -6.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | -0.70% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.00% |
| Operating Margin (TTM) | 0.00% | 0.00% |
| Return on Equity (TTM) | N/A | 0.13% |
| Debt to Equity (MRQ) | 0.00 | 0.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.49 | $-1.56 |
| Cash per Share (MRQ) | $0.00 | $0.02 |
| Operating Cash Flow (TTM) | $-323,234 | $-814,232 |
| Levered Free Cash Flow (TTM) | $0 | $-425,497 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: HCM II Acquisition vs Cartesian Growth
| Metric | HOND | RENEW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 2.18 | N/A |
| Market Capitalization | ||
| Market Capitalization | $493.35M | $1.84B |
| Enterprise Value | $485.18M | $1.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | N/A | -944.18 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.01 |
| Book Value per Share (MRQ) | $-0.49 | $-1.56 |
Financial Statements Comparison: HCM II Acquisition vs Cartesian Growth
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HOND | RENEW |
|---|---|---|
| Revenue/Sales | $0 | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-278,494 | $-195,387 |
| EBITDA | $-278,494 | $-273,251 |
| Pre-Tax Income | $1.07M | $559,864 |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $1.07M | $559,864 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HOND | RENEW |
|---|---|---|
| Cash & Equivalents | $517,160 | $81,252 |
| Total Current Assets | $682,955 | $285,087 |
| Total Current Liabilities | $1.40M | $3.97M |
| Long-Term Debt | N/A | $4.48M |
| Total Shareholders Equity | $225.58M | $64.86M |
| Retained Earnings | $-12.08M | $-20.82M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HOND | RENEW |
|---|---|---|
| Operating Cash Flow | $-273,494 | $-117,523 |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-294,130 | $-155,448 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HOND | RENEW |
|---|---|---|
| Shares Short | 45,339 | N/A |
| Short Ratio | 0.10 | N/A |
| Short % of Float | 0.00% | N/A |
| Average Daily Volume (10 Day) | 3,079,671 | 1,113 |
| Average Daily Volume (90 Day) | 1,477,824 | 371 |
| Shares Outstanding | 28.75M | 13.00M |
| Float Shares | 21.05M | 5.31M |
| % Held by Insiders | 0.00% | N/A |
| % Held by Institutions | 0.99% | N/A |
Dividend Analysis & Yield Comparison: HCM II Acquisition vs Cartesian Growth
| Metric | HOND | RENEW |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.01 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $0.02 |
| Ex-Dividend Date | N/A | Dec 01, 2022 |